KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,808,456 | +1.4% | 187,794 | -5.2% | 0.00% | – |
Q2 2023 | $1,782,639 | +565.8% | 198,071 | +481.5% | 0.00% | – |
Q1 2023 | $267,751 | -63.1% | 34,065 | -68.2% | 0.00% | – |
Q4 2022 | $724,976 | -48.0% | 107,245 | +11.6% | 0.00% | – |
Q3 2022 | $1,394,000 | +45.4% | 96,100 | -1.4% | 0.00% | – |
Q2 2022 | $959,000 | +28.4% | 97,500 | +92.5% | 0.00% | – |
Q1 2022 | $747,000 | -30.8% | 50,658 | -38.0% | 0.00% | – |
Q4 2021 | $1,080,000 | -59.0% | 81,646 | -45.8% | 0.00% | – |
Q3 2021 | $2,631,000 | -37.6% | 150,772 | -14.3% | 0.00% | – |
Q2 2021 | $4,216,000 | -36.3% | 175,953 | -31.7% | 0.00% | -100.0% |
Q1 2021 | $6,616,000 | -37.1% | 257,520 | -53.5% | 0.00% | – |
Q4 2020 | $10,520,000 | +581.8% | 553,966 | +695.6% | 0.00% | – |
Q2 2019 | $1,543,000 | +12.2% | 69,625 | +44.9% | 0.00% | -100.0% |
Q1 2019 | $1,375,000 | +45.7% | 48,060 | +0.5% | 0.00% | – |
Q4 2018 | $944,000 | – | 47,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |